Description
- Atacand 8 is primarily used in managing hypertension.
- It is known for its long-lasting effects on blood pressure regulation.
- AstraZeneca produces Atacand, ensuring a high level of quality in pharmaceutical manufacturing.
- The active ingredient is candesartan cilexetil, an angiotensin II receptor antagonist.
About Atacand 8 AstraZeneca, chemical structure and characteristics
Atacand 8, a medication developed by AstraZeneca, contains candesartan cilexetil as its active component. This drug is classified as an angiotensin II receptor blocker (ARB) and is widely used to treat hypertension and heart failure. The chemical structure of candesartan cilexetil is characterized by its unique molecular configuration, which allows it to effectively block the action of angiotensin II, a peptide hormone that causes blood vessels to constrict.
Candesartan cilexetil is administered in an inactive form, which is rapidly converted to its active form in the body upon ingestion. This characteristic enhances its bioavailability and prolongs its effect, making it a popular choice for those requiring sustained blood pressure control. The half-life of the medication is approximately 9 hours, providing extended therapeutic action. Atacand 8 also offers various dosage forms, catering to individual patient needs.
Benefits for athletic performance, endurance and recovery
For athletes, maintaining optimal cardiovascular function is crucial. Atacand 8 may provide certain benefits in this arena. By regulating blood pressure and promoting better circulation, it can enhance oxygen delivery to muscles during intense training and competition. Improved blood flow may lead to better endurance, allowing athletes to sustain high levels of exertion for longer periods.
Moreover, efficient blood pressure management can facilitate quicker recovery post-exercise. By mitigating the strain on the heart and circulatory system, Atacand 8 may help reduce recovery times, ensuring that athletes can train more frequently and effectively. This can be particularly advantageous in endurance sports, where the demand on the body is continuous. Furthermore, a stable blood pressure profile aids in maintaining energy levels, contributing to improved overall athletic performance.
Buy Atacand 8 AstraZeneca on our website, fast, secure, and verified
When looking to purchase Atacand 8, consider our website as a reliable source. We prioritize customer safety and satisfaction. Our platform is designed to be user-friendly, ensuring that your shopping experience is fast and efficient. Customers can explore our comprehensive catalog, featuring detailed product descriptions and transparent pricing.
We utilize secure payment methods, safeguarding your personal and financial information during transactions. Our commitment to quality means that every product, including Atacand 8 AstraZeneca, is verified and sourced from trustworthy suppliers. Enjoying peace of mind while purchasing this valuable medication is essential, and we ensure that you receive authentic products that meet your health needs.
Contraindications, precautions for use
While Atacand 8 is generally safe for many individuals, certain contraindications must be observed. It is not recommended for individuals with a known allergy to candesartan or any of its components. Additionally, those who are pregnant, nursing, or planning to become pregnant should consult a healthcare provider before using this medication.
Patients with severe liver or kidney issues may also need to approach the use of Atacand 8 with caution. It is important to disclose your complete medical history to a healthcare professional, especially if you are on other medications that may interact negatively with ARBs. Regular monitoring of blood pressure and kidney function is advisable during treatment to ensure safety and efficacy.
Dosage guide
Following the correct dosage of Atacand 8 is vital for maximizing its benefits while minimizing potential side effects. The typical starting dose for adults is 8 mg once daily, which can be adjusted based on individual response and blood pressure goals. The maximum recommended dose is 32 mg per day.
Athletes should consult a healthcare provider for personalized guidance tailored to their specific health requirements and athletic goals. Never self-medicate or change dosages without professional advice, as this could lead to adverse effects. Regular follow-ups with a healthcare provider will assist in determining the most effective dosage and monitoring any potential side effects.
- Atacand 8 can enhance blood pressure regulation for better athletic performance.
- Proper dosage and monitoring are critical to ensure safety and effectiveness.
- Consulting healthcare professionals will provide the best approach to using Atacand 8 in sports.
Additional information
| Active substance | Candesartan Cilexetil |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of blood pressure and renal function may be required |
| Also known as | Candesartan |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Effectively lowers blood pressure |
| Trade name | Atacand |
| Storage conditions | Store at room temperature, protect from moisture and light |
| Chemical name | 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate |
| Formula | C33H34N6O6 |
| Substance class | Angiotensin II receptor blocker |
| Main action | Blocks the action of angiotensin II, resulting in vasodilation and reduction in blood pressure |
| Half-life | Approximately 9 hours |
| Dosage (medical) | Typically 8-32 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Lowers blood pressure, reduces strain on the heart, may improve survival after heart attacks |
| Side effects | Dizziness, headache, back pain, sore throat, abdominal pain, diarrhea |
| Use in sports | Not typically used in sports for performance enhancement |
| Manufacturer | AstraZeneca |





Reviews
There are no reviews yet.